Metabolics altered in RRMS
Metabolics altered in RRMS
http://www.jimmunol.org/content/200/1_Supplement/45.24
Blood-based untargeted metabolomics in Relapsing-Remitting Multiple Sclerosis revealed testable therapeutic target
Abstract
Relapsing-remitting (RRMS), a most common form of MS, is characterized by acute attacks alternated by partial or complete recovery periods. The major focus of our research is to identify the therapeutic target using metabolomics.
Metabolomics is a fast emerging field which can provide a direct “functional readout of the physiological state” of an organism. Identification of blood-based metabolic pathway(s) in relapsing-remitting form of MS (RRMS) which could be used for therapy. Using untargeted ultra-performance liquid and gas mass spectrometry, we measured serum metabolites from 33 RRMS patients, and 14 healthy subjects (HS). A total of 621 known metabolites were detected and 60 metabolites were significantly altered in the serum of RRMS compared to HS.
Bioinformatics analysis revealed four metabolic pathways altered in RRMS including glycerophospholipid, citrate cycle, sphingolipids, and pyruvate metabolism. PBMCs isolated from RRMS patients exhibited higher glycolysis suggesting altered metabolic state of immune cells. EAE mice treated with glycolytic inhibitor 2-deoxyglucose (2-DG; once daily), resulted in a significantly delayed (P<0.001) the disease progression. 2DG inhibited (P<0.01) interleukin 17 production by reducing glycolysis (P<0.01) in monocytes of treated EAE group.
Using untargeted metabolomic and Seahorse bioanalyzer approaches, we document that RRMS patients showed altered metabolic state “metabotype”. Targeting glycolysis, upstream of metabolic pathways altered in RRMS, using pharmacological inhibitor ameliorated the disease progression and pathology in a preclinical model of MS.
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 61 Views
-
Last post by frodo
Tue Jan 05, 2021 3:00 pm
-
-
CSF can separate RRMS from PPMS
by frodo » Sun Feb 03, 2019 7:49 am » in MS Etiology and Pathogenesis - 0 Replies
- 965 Views
-
Last post by frodo
Sun Feb 03, 2019 7:49 am
-
-
-
Lipoic acid modulates inflammatory response in RRMS
by NHE » Thu Aug 27, 2020 2:04 am » in Natural Approach - 0 Replies
- 202 Views
-
Last post by NHE
Thu Aug 27, 2020 2:04 am
-
-
-
2017: Health Canada approves oral Mavenclad™ for RRMS
by jimmylegs » Sat Feb 09, 2019 8:26 am » in Mavenclad (Cladribine) - 0 Replies
- 1359 Views
-
Last post by jimmylegs
Sat Feb 09, 2019 8:26 am
-
-
-
Fish oil normalizes membrane fluidity and mitochondrial ATPase activity in RRMS
by NHE » Thu Jan 30, 2020 3:31 am » in Natural Approach - 0 Replies
- 6510 Views
-
Last post by NHE
Thu Jan 30, 2020 3:31 am
-